Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
55,101,964
-
Share change
-
-10,127,753
-
Total reported value
-
$111,298,078
-
Put/Call ratio
-
79%
-
Price per share
-
$2.02
-
Number of holders
-
136
-
Value change
-
-$22,169,179
-
Number of buys
-
68
-
Number of sells
-
60
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q1 2022
As of 31 Mar 2022,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,101,964 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Palo Alto Investors LP, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, HRT FINANCIAL LP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.